Principal Financial Group Inc Mirati Therapeutics, Inc. Transaction History

Principal Financial Group Inc

$162 Billion
Q1 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 07, 2024	SELL	$41.99 - $62.38 $23,808 - $35,369	-567 Reduced 5.0%	10,784 $633,000
Q3 2023 Nov 02, 2023	BUY	$27.8 - $45.35 $9,869 - $16,099	355 Added 3.23%	11,351 $494,000
Q2 2023 Aug 07, 2023	SELL	$36.13 - $49.49 $42,488 - $58,200	-1,176 Reduced 9.66%	10,996 $397,000
Q1 2023 May 09, 2023	SELL	$36.54 - $54.26 $11,327 - $16,820	-310 Reduced 2.48%	12,172 $452,000
Q4 2022 Feb 09, 2023	BUY	$41.27 - $98.62 $49,193 - $117,555	1,192 Added 10.56%	12,482 $565,000

Q3 2022 Nov 09, 2022	BUY	$59.5 - $86.7 $29,690 - $43,263	499 Added 4.62%	11,290 $789,000
Q2 2022 Aug 10, 2022	BUY	$39.16 - $88.71 $27,529 - $62,363	703 Added 6.97%	10,791 $724,000
Q1 2022 May 09, 2022	SELL	$75.82 - $150.97 $26,688 - $53,141	-352 Reduced 3.37%	10,088 $829,000
Q4 2021 Feb 09, 2022	SELL	$132.01 - $190.29 $480,912 - $693,226	-3,643 Reduced 25.87%	10,440 $1.53 Million
Q3 2021 Nov 09, 2021	SELL	$132.13 - $177.45 $244,176 - $327,927	-1,848 Reduced 11.6%	14,083 $2.49 Million
Q2 2021 Aug 10, 2021	SELL	$144.0 - $179.73 $5.88 Million - $7.34 Million	-40,812 Reduced 71.92%	15,931 $2.57 Million
Q1 2021 May 10, 2021	BUY	$158.92 - $221.61 $5.21 Million - $7.26 Million	32,773 Added 136.73%	56,743 $9.72 Million
Q4 2020 Feb 08, 2021	BUY	$162.05 - $240.27 $141,955 - $210,476	876 Added 3.79%	23,970 $5.27 Million
Q3 2020 Nov 06, 2020	SELL	$113.26 - $167.27 $69,428 - $102,536	-613 Reduced 2.59%	23,094 $3.83 Million
Q2 2020 Aug 05, 2020	BUY	$72.01 - $120.39 $465,112 - $777,599	6,459 Added 37.45%	23,707 $2.71 Million
Q1 2020 May 12, 2020	BUY	$69.78 - $116.21 $164,959 - $274,720	2,364 Added 15.88%	17,248 $1.33 Million
Q4 2019 Feb 05, 2020	BUY	$70.76 - $128.86 $3,679 - $6,700	52 Added 0.35%	14,884 $1.92 Million
Q3 2019 Nov 13, 2019	BUY	$77.91 - $109.6 $66,768 - $93,927	857 Added 6.13%	14,832 $1.16 Million
Q2 2019 Aug 12, 2019	BUY	$59.49 - $104.71 $84,237 - $148,269	1,416 Added 11.27%	13,975 $1.44 Million
Q1 2019 May 10, 2019	BUY	$43.65 - $78.95 $548,200 - $991,533	12,559 New	12,559 $921,000
Q4 2018 Feb 14, 2019	SELL	$32.0 - $47.43 $143,136 - $212,154	-4,473 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$47.1 - $62.7 $10,456 - $13,919	222 Added 5.22%	4,473 $211,000
Q2 2018 Aug 13, 2018	BUY	$26.05 - $52.4 $110,738 - $222,752	4,251 New	4,251 $0

Others Institutions Holding MRTX

# of Institutions

Shares Held

3.57M

Call Options Held

Put Options Held

36.6K

View Full List

About Mirati Therapeutics, Inc.

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

More about MRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.

Account